RESUMO
alpha-Galactosylceramide (alphaGalCer) stimulates NKT cells and has antitumor activity in mice. Murine NKT cells may directly kill tumor cells and induce NK cell cytotoxicity, but the mechanisms are not well defined. Newly developed human CD1d/alphaGalCer tetrameric complexes were used to obtain highly purified human alphaGalCer-reactive NKT cell lines (>99%), and the mechanisms of NKT cell cytotoxicity and activation of NK cells were investigated. Human NKT cells were cytotoxic against CD1d(-) neuroblastoma cells only when they were rendered CD1d(+) by transfection and pulsed with alphaGalCer. Four other CD1d(-) tumor cell lines of diverse origin were resistant to NKT cells, whereas Jurkat and U937 leukemia cell lines, which are constitutively CD1d(+), were killed. Killing of the latter was greatly augmented in the presence of alphaGalCer. Upon human CD1d/alphaGalCer recognition, NKT cells induced potent cytotoxicity of NK cells against CD1d(-) neuroblastoma cell lines that were not killed directly by NKT cells. NK cell activation depended upon NKT cell production of IL-2, and was enhanced by secretion of IFN-gamma. These data demonstrate that cytotoxicity of human NKT cells can be CD1d and ligand dependent, and that TCR-stimulated NKT cells produce IL-2 that is required to induce NK cell cytotoxicity. Thus, NKT cells can mediate potent antitumor activity both directly by targeting CD1d and indirectly by activating NK cells.
Assuntos
Adjuvantes Imunológicos/farmacologia , Antígenos CD1/imunologia , Antineoplásicos/farmacologia , Citotoxicidade Imunológica/imunologia , Galactosilceramidas/farmacologia , Interleucina-2/fisiologia , Células Matadoras Naturais/imunologia , Ativação Linfocitária/fisiologia , Subpopulações de Linfócitos T/imunologia , Adulto , Animais , Antígenos CD1d , Carcinoma de Células Pequenas/patologia , Linhagem Celular/efeitos dos fármacos , Linhagem Celular/imunologia , Citocinas/biossíntese , Citocinas/farmacologia , Testes Imunológicos de Citotoxicidade , Células HL-60 , Células HeLa , Humanos , Separação Imunomagnética , Imunofenotipagem , Interferon gama/metabolismo , Células Jurkat , Ligantes , Neoplasias Pulmonares/patologia , Ativação Linfocitária/efeitos dos fármacos , Melanoma/patologia , Camundongos , Neuroblastoma/patologia , Receptores de Antígenos de Linfócitos T/imunologia , Proteínas Recombinantes/farmacologia , Subpopulações de Linfócitos T/efeitos dos fármacos , Transfecção , Células Tumorais Cultivadas , Células U937RESUMO
Analysis of cytokine and differentiation antigen expression in human natural killer (NK) cells revealed that interleukin 13 (IL-13) and interferon gamma (IFN-gamma) are produced at sequential stages during irreversible IL-12-induced differentiation. In human NK cell clones, polyclonal CD3-CD161+CD56- cells and peripheral lymphocytes, IL-4 induced the proliferation of both IL-13+ NK and T cells, whereas IL-12 allowed a proliferation-independent accumulation of IFN-gamma+ cells. These data disproved the NK1-NK2 hypothesis and challenge the current T helper 1 (TH1)-TH2 paradigm. We propose that the cytokine environment regulates a type 2-->0-->1 developmental progression, with IL-12 needed for terminal differentiation and IL-4 delaying this process, rather than a type 1 versus type 2 decision of a type 0 cell.
Assuntos
Células Matadoras Naturais/imunologia , Modelos Imunológicos , Células Th1/imunologia , Células Th2/imunologia , Antígenos de Diferenciação/análise , Diferenciação Celular , Células Cultivadas , Células Clonais , Testes Imunológicos de Citotoxicidade , Humanos , Interferon gama/biossíntese , Interleucina-13/biossíntese , Ativação Linfocitária , Subpopulações de Linfócitos/classificação , Receptores Imunológicos/metabolismoRESUMO
The human B-myb gene encodes a transcriptional regulator that plays an important role in cell cycle progression, differentiation, and survival. To assess the in vivo role of B-myb, we investigated the phenotype of mouse transgenic lines in which B-Myb expression in lymphoid tissues was driven by the LCK proximal promoter. Overexpression of B-Myb had no measurable effect on the subsets of splenic and thymic lymphocytes, but was associated with increased expression of Fas ligand in NK and T cells. B-Myb-overexpressing splenocytes expressed higher IFN-gamma levels and contained higher percentages of cytokine-producing cells than wild-type (wt) splenocytes, as detected by Western blot analysis and ELISPOT assays, respectively. Ex vivo-cultured transgenic thymocytes and splenocytes had decreased survival compared with the corresponding cells from wt mice, possibly dependent on increased expression of Fas ligand. In addition, Fas ligand-dependent cytotoxicity of transgenic T and NK cells was significantly higher than that mediated by their wt counterparts. Together, these results indicate that B-Myb overexpression results in T and NK cell activation and increased cytotoxicity. Therefore, in addition to its well-established role in proliferation and differentiation, B-myb also appears to be involved in activation of NK and T cells and in their regulation of Fas/Fas ligand-mediated cytotoxicity
Assuntos
Proteínas de Ciclo Celular , Citotoxicidade Imunológica , Proteínas de Ligação a DNA/biossíntese , Proteínas de Ligação a DNA/genética , Células Matadoras Naturais/imunologia , Ativação Linfocitária , Glicoproteínas de Membrana/fisiologia , Linfócitos T Citotóxicos/imunologia , Transativadores/biossíntese , Transativadores/genética , Receptor fas/fisiologia , Animais , Sobrevivência Celular/genética , Sobrevivência Celular/imunologia , Células Cultivadas , Cruzamentos Genéticos , Testes Imunológicos de Citotoxicidade , Citotoxicidade Imunológica/genética , Proteína Ligante Fas , Humanos , Interferon gama/biossíntese , Interferon gama/genética , Células Jurkat , Células Matadoras Naturais/citologia , Ligantes , Ativação Linfocitária/genética , Proteína Tirosina Quinase p56(lck) Linfócito-Específica/genética , Glicoproteínas de Membrana/biossíntese , Glicoproteínas de Membrana/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Linfócitos T Citotóxicos/citologiaRESUMO
The serine-threonine mitogen-activated protein kinase (MAPK) family includes extracellular signal-regulated kinases (ERK), c-Jun N-terminal kinases (JNK), and p38 kinases. In NK cells, spontaneous or Ab-mediated recognition of target cells leads to activation of an ERK-2 MAPK-dependent biochemical pathway(s) involved in the regulation of NK cell effector functions. Here we assessed the roles of p38 and JNK MAPK in NK cell-mediated cytotoxicity. Our data indicate that p38 is activated in primary human NK cells upon stimulation with immune complexes and interaction with NK-sensitive target cells. FcgammaRIIIA-induced granule exocytosis and both spontaneous and Ab-dependent cytotoxicity were reduced in a dose-dependent manner in cells pretreated with either of two specific inhibitors of this kinase. Target cell-induced IFN-gamma and FcgammaRIIIA-induced TNF-alpha mRNA accumulation was similarly affected under the same conditions. Lack of inhibition of NK cell cytotoxicity in cells overexpressing an inactive form of JNK1 indicates that this kinase, activated only upon FcgammaRIIIA ligation, does not play a significant role in cytotoxicity. These data underscore the involvement of p38, but not JNK1, in the molecular mechanisms regulating NK cell cytotoxicity.
Assuntos
Citotoxicidade Imunológica/imunologia , Células Matadoras Naturais/enzimologia , Células Matadoras Naturais/imunologia , Proteínas Quinases Ativadas por Mitógeno/fisiologia , Actinas/metabolismo , Citotoxicidade Celular Dependente de Anticorpos/imunologia , Linhagem Celular , Células Cultivadas , Citocinas/biossíntese , Citocinas/genética , Citocinas/metabolismo , Grânulos Citoplasmáticos/imunologia , Testes Imunológicos de Citotoxicidade , Ativação Enzimática/imunologia , Exocitose/imunologia , Humanos , Proteínas Quinases JNK Ativadas por Mitógeno , Células K562 , Células Matadoras Naturais/metabolismo , RNA Mensageiro/biossíntese , RNA Mensageiro/metabolismo , Receptores de IgG/fisiologia , Proteínas Quinases p38 Ativadas por MitógenoAssuntos
Citotoxicidade Imunológica , Células Matadoras Naturais/imunologia , Citotoxicidade Celular Dependente de Anticorpos , Humanos , Integrinas/metabolismo , Células Matadoras Naturais/metabolismo , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Fosfatidilinositol 3-Quinases/metabolismo , Receptores de IgG/metabolismo , Transdução de Sinais , Proteínas ras/metabolismoRESUMO
Extracellular signal-regulated kinases (ERK, also known as mitogen-activated protein kinases) are serine-threonine kinases transducing signals elicited upon ligand binding to several tyrosine kinase-associated receptors. We have reported that ERK2 phosphorylation and activation follows engagement of the low affinity receptor for the Fc portion of IgG (CD16) on NK cells, and is necessary for CD16-induced TNF-alpha mRNA expression. Here, we analyzed the involvement of ERK in NK cell-mediated cytotoxicity and IFN-gamma expression induced upon stimulation with targets cells, coated or not with Abs. Our data indicate that, as with immune complexes, ERK2 phosphorylation occurs in human primary NK cells upon interaction with target cells sensitive to granule exocytosis-mediated spontaneous cytotoxicity, and that this regulates both target cell- and immune complex-induced cytotoxicity and IFN-gamma mRNA expression. A specific inhibitor of mitogen-activated protein kinase kinase reduced both spontaneous and Ab-dependent cytotoxicity in a dose-dependent manner involving, at least in part, inhibition of granule exocytosis without affecting effector/target cell interaction and rearrangement of the cytoskeleton proteins actin and tubulin. Involvement of ERK in the regulation of Ca2+-dependent cell-mediated cytotoxicity was confirmed, using a genetic approach, in primary NK cells infected with a recombinant vaccinia virus encoding an ERK inactive mutant. These data indicate that the biochemical pathways elicited in NK cells upon engagement of receptors responsible for either spontaneous or Ab-dependent recognition of target cells, although distinct, utilize ERK as one of their downstream molecules to regulate effector functions.
Assuntos
Proteínas Quinases Dependentes de Cálcio-Calmodulina/fisiologia , Citotoxicidade Imunológica/fisiologia , Espaço Extracelular/enzimologia , Células Matadoras Naturais/imunologia , MAP Quinase Quinase Quinase 1 , Proteínas Quinases Ativadas por Mitógeno , Transdução de Sinais/fisiologia , Actinas/análise , Animais , Citotoxicidade Celular Dependente de Anticorpos/fisiologia , Cálcio/farmacologia , Proteínas Quinases Dependentes de Cálcio-Calmodulina/genética , Grânulos Citoplasmáticos/metabolismo , Citoesqueleto/ultraestrutura , Relação Dose-Resposta Imunológica , Ativação Enzimática , Inibidores Enzimáticos/farmacologia , Exocitose , Flavonoides/farmacologia , Humanos , Interferon gama/metabolismo , Células Jurkat , Camundongos , Proteína Quinase 1 Ativada por Mitógeno , Proteína Quinase 3 Ativada por Mitógeno , Fosforilação/efeitos dos fármacos , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Proteínas Serina-Treonina Quinases/metabolismo , RNA Mensageiro/biossíntese , Receptores de IgG/imunologia , Proteínas Recombinantes de Fusão/metabolismo , Acetato de Tetradecanoilforbol/farmacologia , Tubulina (Proteína)/análise , Células Tumorais CultivadasRESUMO
Mature natural killer (NK) cells use Ca2+-dependent granule exocytosis and release of cytotoxic proteins, Fas ligand (FasL), and membrane-bound or secreted cytokines (tumor necrosis factor [TNF]-alpha) to induce target cell death. Fas belongs to the TNF receptor family of molecules, containing a conserved intracytoplasmic "death domain" that indirectly activates the caspase enzymatic cascade and ultimately apoptotic mechanisms in numerous cell types. Two additional members of this family, DR4 and DR5, transduce apoptotic signals upon binding soluble TNF-related apoptosis-inducing ligand (TRAIL) that, like FasL, belongs to the growing TNF family of molecules. Here, we report that TRAIL produced or expressed by different populations of primary human NK cells is functional, and represents a marker of differentiation or activation of these, and possibly other, cytotoxic leukocytes. During differentiation NK cells, sequentially and differentially, use distinct members of the TNF family or granule exocytosis to mediate target cell death. Phenotypically immature CD161(+)/CD56(-) NK cells mediate TRAIL-dependent but not FasL- or granule release-dependent cytotoxicity, whereas mature CD56(+) NK cells mediate the latter two.
Assuntos
Citotoxicidade Imunológica , Células Matadoras Naturais/imunologia , Glicoproteínas de Membrana/fisiologia , Fator de Necrose Tumoral alfa/fisiologia , Anticorpos Monoclonais/farmacologia , Antígenos CD/análise , Apoptose/efeitos dos fármacos , Proteínas Reguladoras de Apoptose , Cálcio/metabolismo , Degranulação Celular , Diferenciação Celular , Células Cultivadas , Citotoxicidade Imunológica/efeitos dos fármacos , Proteína Ligante Fas , Humanos , Interleucinas/farmacologia , Células Matadoras Naturais/citologia , Células Matadoras Naturais/efeitos dos fármacos , Glicoproteínas de Membrana/genética , RNA Mensageiro/análise , Receptores do Fator de Necrose Tumoral/metabolismo , Proteínas Recombinantes de Fusão/farmacologia , Ligante Indutor de Apoptose Relacionado a TNF , Células Tumorais Cultivadas , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/imunologia , Receptor fas/fisiologiaRESUMO
Cytokine-mediated enhancement of spontaneous cytotoxicity depends, at least in part, on modulation of the expression of surface molecules responsible for recognition of target cell structures and triggering or inhibition of the cytotoxic machinery. We previously demonstrated that expression of transcription factors (e.g., Egr-1, JunB, and c-Fos) is differentially regulated by IL-2 and IL-12. Here we show that expression of CD161/NKR-P1A, a molecule involved in triggering cytotoxicity, is specifically upregulated by IL-12. CD161 transcription, mRNA accumulation, and surface expression are increased by IL-12. Other cytokines sharing the IL-2R beta- and/or common gamma-chains (i.e., IL-15, IL-4, and IL-7) do not mediate these effects. In an effort to analyze the mechanisms by which IL-2, IL-12, and IL-15 differentially regulate gene transcription, we have isolated a novel gene, 197/15a, the expression of which in NK and T cells is down-regulated by IL-2 and IL-15, up-regulated by IL-12, and not affected by IL-4 and IL-7. IL-2 and IL-15 act, at least in part, repressing 197/15a transcription; their effect on 197/15a mRNA accumulation is partially independent of novel protein synthesis, likely not mediated by JunB, Bcl-2, or Bax, and requires the activity of rapamycin-sensitive molecule(s). The observation that IL-2 and IL-12 differentially modulate CD161 expression suggests the existence of cytokine-specific mechanisms of modulation of spontaneous cytotoxicity based on the regulation of expression of surface molecules involved in target cell recognition and/or triggering of the cytolytic machinery.
Assuntos
Antígenos de Superfície/genética , Proteínas de Ciclo Celular , Interleucinas/farmacologia , Células Matadoras Naturais/metabolismo , Lectinas Tipo C , Proteínas/genética , Proteínas de Ligação a RNA , Subpopulações de Linfócitos T/metabolismo , Transcrição Gênica/imunologia , Sequência de Aminoácidos , Animais , Antígenos de Superfície/biossíntese , Antígenos de Superfície/fisiologia , Proteínas Reguladoras de Apoptose , Células Clonais , Citocinas/metabolismo , Citocinas/fisiologia , Citotoxicidade Imunológica , Regulação da Expressão Gênica/imunologia , Humanos , Interleucina-12/farmacologia , Interleucina-15/farmacologia , Interleucina-2/farmacologia , Células Matadoras Naturais/imunologia , Camundongos , Dados de Sequência Molecular , Subfamília B de Receptores Semelhantes a Lectina de Células NK , Biossíntese de Proteínas , Proteínas/química , Receptores de Interleucina/fisiologia , Homologia de Sequência do Ácido Nucleico , Subpopulações de Linfócitos T/imunologia , Transcrição Gênica/efeitos dos fármacos , Células Tumorais CultivadasRESUMO
We used a monoclonal antibody (mAb) (B203.13, IgM) generated from a mouse immunized with the human B/myeloid bi-phenotypic B1b cell line, to analyse haemopoietic cells. The antigen recognized by this mAb is expressed on most adult and umbilical cord blood CD21+ B cells, at minimal density on mature monocytes, and is undetectable on granulocytes, T, natural killer (NK) cells, and erythrocytes. Within umbilical cord blood and adult bone marrow haemopoietic progenitor cells, the B203.13 mAb recognized a surface marker, present on progenitor cells of several haemopoietic lineages, that was transiently expressed on early erythroid and T/NK progenitors, and was preferentially maintained on cells of the B and myeloid lineages. Within the CD34+ cells, B203.13 was expressed on early committed myeloid (CD33+) and erythroid (CD71dim) progenitor cells, as confirmed in colony formation assays. The mAb also reacted with cells of B and myeloid chronic leukaemias and cell lines. These data define B203.13 mAb as a novel reagent useful for the characterization of haemopoietic progenitors and leukaemias.
Assuntos
Antígenos de Superfície/análise , Linfócitos B/imunologia , Medula Óssea/imunologia , Células-Tronco Hematopoéticas/imunologia , Adulto , Animais , Anticorpos Monoclonais , Antígenos de Neoplasias/análise , Diferenciação Celular/imunologia , Ensaio de Unidades Formadoras de Colônias , Epitopos/análise , Feminino , Sangue Fetal/imunologia , Humanos , Recém-Nascido , Leucemia/imunologia , Masculino , Camundongos , Pessoa de Meia-Idade , Células Tumorais CultivadasRESUMO
To determine the possible role of the BCR/ABL oncoprotein SH3 domain in BCR/ABL-dependent leukemogenesis, we studied the biologic properties of a BCR/ABL SH3 deletion mutant (delta SH3 BCR/ABL) constitutively expressed in murine hematopoietic cells. delta SH3 BCR/ABL was able to activate known BCR/ABL-dependent downstream effector molecules such as RAS, PI-3kinase, MAPK, JNK, MYC, JUN, STATs, and BCL-2. Moreover, expression of delta SH3 BCR/ABL protected 32Dcl3 murine myeloid precursor cells from apoptosis, induced their growth factor-independent proliferation, and resulted in transformation of primary bone marrow cells in vitro. Unexpectedly, leukemic growth from cells expressing delta SH3 BCR/ABL was significantly retarded in SCID mice compared with that of cells expressing the wild-type protein. In vitro and in vivo studies to determine the adhesive and invasive properties of delta SH3 BCR/ABL-expressing cells showed their decreased interaction to collagen IV- and laminin-coated plates and their reduced capacity to invade the stroma and to seed the bone marrow and spleen. The decreased interaction with collagen type IV and laminin was consistent with a reduced expression of alpha 2 integrin by delta SH3 BCR/ABL-transfected 32Dcl3 cells. Moreover, as compared with wild-type BCR/ABL, which localizes primarily in the cytoskeletal/membrane fraction, delta SH3 BCR/ABL was more evenly distributed between the cytoskeleton/membrane and the cytosol compartments. Together, the data indicate that the SH3 domain of BCR/ABL is dispensable for in vitro transformation of hematopoietic cells but is essential for full leukemogenic potential in vivo.
Assuntos
Movimento Celular/genética , Transformação Celular Neoplásica , Proteínas de Fusão bcr-abl/genética , Regulação Neoplásica da Expressão Gênica , Leucemia Experimental/patologia , Domínios de Homologia de src/genética , Animais , Adesão Celular/genética , Linhagem Celular , Leucemia Experimental/genética , CamundongosRESUMO
G-protein-coupled receptor kinases (GRKs) mediate agonist-specific phosphorylation and desensitization of G-protein-coupled receptors. Previous studies have shown that several of these kinases are expressed in hematopoietic cells and that GRK expression is modulated during T-lymphocyte activation. Here, we analyzed the regulation of beta-adrenergic receptor kinase (betaARK) and GRK6 expression and activity in myelomonocytic and lymphoid cells. In the promyelocytic cell line HL-60, GRK6 protein levels and activity rose twofold to fourfold over the course of treatment with agents that induce differentiation toward either the myeloid (dimethyl sulfoxide and retinoic acid) or monocytic [1alpha,25(OH)2-vitamin D3] lineage, whereas betaARK protein levels and activity were only slightly altered. In contrast, treatment with phorbol 12,13-myristic acetate (PMA) led to a reduction in steady-state levels and activity of both betaARK and GRK6. Treatment of human lymphocytes with several polyclonal activators (phytohemagglutinin, anti-CD3 antibody and interleukin-2) resulted in enhanced betaARK and GRK6 mRNA and protein levels and increased activity of both kinases. In contrast, PMA and calcium ionophore treatment significantly elevated GRK6 protein levels, while decreasing betaARK expression. These data demonstrate that betaARK and GRK6 expression are differentially regulated during myelomonocytic cell development and lymphocyte activation.
Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/genética , Proteínas Serina-Treonina Quinases , Receptores Proteína Tirosina Quinases/genética , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Quinases de Receptores Acoplados a Proteína G , Regulação Leucêmica da Expressão Gênica , Células HL-60/química , Células-Tronco Hematopoéticas , Humanos , Ativação Linfocitária/fisiologia , Monócitos/química , RNA Mensageiro/análise , Receptores Proteína Tirosina Quinases/metabolismo , Quinases de Receptores Adrenérgicos betaRESUMO
Human natural killer (NK) cell differentiation from immature lineage negative (Lin-) umbilical cord blood cells was examined in vitro. Cells expressing differentiation antigens of mature NK cells (CD56, CD16, CD2, CD8, NKR-P1A) were generated from Lin- cells cultured with interleukin (IL)-2 and a murine bone marrow stromal cell line expressing the human membrane-bound form of stem cell factor. Two subsets of NK cells were identified in these cultures: one expressed both NKR-P1A and CD56 and, in variable proportions, all other NK cell differentiation antigens; the second subset expressed only NKR-P1A and, unlike the former, was not cytotoxic. Neither subset expressed interferon (IFN)-gamma mRNA even after stimulation with phorbol di-ester and Ca2+ ionophore, but both expressed tumor necrosis factor alpha mRNA and the cytotoxic granule-associated proteins TIA-1, perforin, and serine esterase-1. After 10-d culture with IL-2, IL-12, and irradiated B lymphoblastoid cells, approximately 45% of the NKR-P1A+/ CD56- cells became CD56+, and the same cultures contained cells capable of cytotoxicity and of IFN-gamma production. These results indicate that NKR-P1A expression in the absence of other NK cell markers defines an intermediate, functionally immature stage of NK cell differentiation, and that effector functions develop in these cells, concomitantly with CD56 expression, in the presence of IL-12. These cells likely represent the counterpart of a CD3-/NKR-P1A+/ CD56-/CD16- cell subset that, as shown here, is present both in adult and neonatal circulating lymphocytes.
Assuntos
Antígenos de Diferenciação/análise , Células-Tronco Hematopoéticas/efeitos dos fármacos , Interleucina-12/farmacologia , Células Matadoras Naturais/efeitos dos fármacos , Lectinas Tipo C , Subpopulações de Linfócitos/efeitos dos fármacos , Adulto , Animais , Antígenos de Superfície/análise , Complexo CD3/análise , Antígeno CD56/análise , Diferenciação Celular , Linhagem da Célula , Técnicas de Cultura/métodos , Citotoxicidade Imunológica , Sangue Fetal , Humanos , Interferon gama/biossíntese , Leucócitos Mononucleares , Camundongos , Subfamília B de Receptores Semelhantes a Lectina de Células NK , Receptores de IgG/análiseRESUMO
The responses of lymphocytes to IL-2 and IL-12, involving proliferation, differentiation, and cytokine production, are only partially overlapping, and may depend on induced differential expression of specific sets of genes. Using reverse-transcription PCR differential display, we isolated an mRNA species expressed in IL-2- but not IL-12-stimulated NK cells. This was identified as the mRNA encoding the transcription factor egr-1, which is expressed with fast kinetics in T and NK cells upon IL-2, but not IL-12, stimulation. Analysis of the accumulation of mRNA-encoding members of the AP-1 transcription factor family demonstrated that c-fos and junB are also expressed upon stimulation of NK and T cells with IL-2, but not IL-12, whereas expression of c-jun and junD is not modified by either cytokine. Accordingly, increased AP-1 DNA-binding activity and AP-1-dependent transcriptional activity were detected exclusively in IL-2-stimulated cells. Analysis of the expression of genes reported to regulate cytokine-induced proliferation demonstrated that both IL-2 and IL-12 induce c-myc mRNA accumulation in NK and T cells, whereas only IL-2 induces bcl-2 expression. Our data provide the first demonstration that IL-12-mediated activation of T and NK cells does not involve expression of members of the immediate-early activation genes family (egr-1, c-fos, and junB), AP-1 transcriptional activity, or bcl-2 expression. This indicates that functional differences observed in IL-2- and IL-12-stimulated cells may depend, at least in part, on differential gene regulation.
Assuntos
Genes Precoces , Proteínas Imediatamente Precoces , Interleucina-12/farmacologia , Células Matadoras Naturais/imunologia , Linfócitos T/imunologia , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Proteína 1 de Resposta de Crescimento Precoce , Regulação da Expressão Gênica , Genes fos , Genes jun , Genes myc , Humanos , Técnicas In Vitro , Interleucina-2/farmacologia , Ativação Linfocitária , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Fator de Transcrição AP-1/genética , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismoRESUMO
Cross-linking the receptors for the Fc domain of IgG (Fc gamma R) on leukocytes induces activation of protein tyrosine kinases. The intermediary molecules that transduce to the nucleus the signals leading to induction of the diverse biological responses mediated by these receptors are not clearly identified. We have investigated whether mitogen-activated protein kinases (MAPK) are involved in transmembrane signaling via the three Fc gamma R present on monocytic, polymorphonuclear, and natural killer (NK) cells. Our results indicate that occupancy of Fc gamma RI and Fc gamma RII on the monocytic cell line THP-I and on polymorphonuclear leukocytes (PMN) induces, transiently and with fast kinetics, MAPK phosphorylation, as indicated by decreased electrophoretic mobility in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and increased amounts of the proteins in antiphosphotyrosine antibody immunoprecipitates. This, associated with increased enzymatic activity, also occurs upon stimulation of the transmembrane isoform of CD16 (Fc gamma RIIIA) in NK cells and in a T cell line expressing transfected Fc gamma RIIIA alpha ligand-binding chain in association with zeta, but not upon stimulation of the glycosil-phosphatidylinositol-anchored Fc gamma RIIIB on PMN. Using the specific MAP kinase kinase inhibitor-PD 098059, we show that activation of MAPK is necessary for the Fc gamma R-dependent induction of c-fos and tumor necrosis factor alpha mRNA expression in monocytes and NK cells. These results underscore the role of MAPK as signal-transducing molecules controlling the expression of different genes relevant to leukocyte biology upon Fc gamma R stimulation.
Assuntos
Regulação Enzimológica da Expressão Gênica , Leucócitos/enzimologia , Proteínas Quinases Ativadas por Mitógeno , Receptores de IgG/metabolismo , Transdução de Sinais , Fator de Necrose Tumoral alfa/biossíntese , Animais , Proteínas Quinases Dependentes de Cálcio-Calmodulina/metabolismo , Eletroforese em Gel de Poliacrilamida , Ativação Enzimática , Humanos , Células Matadoras Naturais/metabolismo , Cinética , Camundongos , Proteína Quinase 1 Ativada por Mitógeno , Proteína Quinase 3 Ativada por Mitógeno , Fosforilação , Células Th1/metabolismo , Células Tumorais CultivadasRESUMO
The evidence accumulated in the past few years has indicated that natural killer (NK) cells, originally identified on the basis of their ability to mediate spontaneous cytotoxicity, play a primary role in regulating immune responses and homeostasis via release of cytokines. Polyclonal populations of NK cells can be induced to produce an overlapping set of soluble factors. Some of these, represented primarily by IFN-gamma, TNF-alpha, and several growth factors for hematopoietic cells, have been clearly identified; others may represent novel cytokines. Production of specific cytokine subsets by distinct NK-cell subpopulations has not been documented, and the same cytokines are produced, in response to distinct stimuli, by both resting and activated NK cells, with the differences being for the most part quantitative, rather than qualitative. No cytokines capable of regulating NK-cell proliferation in an autocrine fashion have been described, and, with the exception of IL-5, cytokine production is not correlated with the proliferative capability of the cells. In this review, the stimuli leading to cytokine production are discussed in light of the knowledge of the molecular mechanisms by which distinct ligands (target cells, ligands for specific receptors, antibodies to triggering molecules, cytokines) regulate expression of cytokine-encoding genes and variably modulate each others' effects. The biological consequences of the production of specific cytokines are related to their effects on the NK cells themselves and on other hematopoietic and nonhematopoietic cell types. These are discussed, in an attempt to provide a picture that helps in understanding how NK cells may participate in regulating inflammatory and immune responses independently, at least in part, of their cytotoxic functions.